Morin

CAS# 480-16-0

Morin

2D Structure

Catalog No. BCN1028----Order now to get a substantial discount!

Product Name & Size Price Stock
Morin: 5mg $23 In Stock
Morin: 10mg Please Inquire In Stock
Morin: 20mg Please Inquire Please Inquire
Morin: 50mg Please Inquire Please Inquire
Morin: 100mg Please Inquire Please Inquire
Morin: 200mg Please Inquire Please Inquire
Morin: 500mg Please Inquire Please Inquire
Morin: 1000mg Please Inquire Please Inquire

Quality Control of Morin

3D structure

Package In Stock

Morin

Number of papers citing our products

Chemical Properties of Morin

Cas No. 480-16-0 SDF Download SDF
PubChem ID 5281670 Appearance Light brown powder
Formula C15H10O7 M.Wt 302.24
Type of Compound Flavonoids Storage Desiccate at -20°C
Synonyms 2'-Hydroxypelargidenolon 1522; 2',3,4',5,7-Pentahydroxyflavone; 2',4',5,7-Tetrahydroxyflavonol
Solubility Soluble in methanol; slightly soluble in water
Chemical Name 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one
SMILES C1=CC(=C(C=C1O)O)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O
Standard InChIKey YXOLAZRVSSWPPT-UHFFFAOYSA-N
Standard InChI InChI=1S/C15H10O7/c16-6-1-2-8(9(18)3-6)15-14(21)13(20)12-10(19)4-7(17)5-11(12)22-15/h1-5,16-19,21H
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Source of Morin

The root bark of Morus alba L.

Biological Activity of Morin

DescriptionMorin, a α-glucosidase inhibitor with an IC50 value of (4.48 ± 0.04) uM, it also exhibits inhibition in the generation of advanced glycation end products which was related to the long term complications of diabetes. Morin has anti-inflammatory and anti-oxidative effects by activating Nrf2 signal pathways and inhibiting NF-κB activation. it can be used to prevent bladder cancer, it prevents MMP-9 expression via the inhibition of transcription factors AP-1, Sp-1, and NF-κB.
TargetsNrf2 | IL Receptor | TNF-α | NF-kB | Nrf2 | HO-1 | TLR | p38MAPK | ERK | CDK | p21 | JNK | Akt | MMP(e.g.TIMP) | AP-1 | P-gp | α-glucosidase | Sp-1
In vitro

Morin activates the Nrf2-ARE pathway and reduces oxidative stress-induced DNA damage in pancreatic beta cells.[Pubmed: 28216051 ]

Eur J Pharmacol. 2017 Apr 15;801:9-18.

Oxidative stress is an important factor contributing to the pathogenesis of diabetes and its complications. In our earlier study, we demonstrated the antidiabetic efficacy of Morin by regulating key enzymes of carbohydrate metabolism in diabetic rats. The present study was designed to assess the antigenotoxic potential of Morin in pancreatic β-cells, using the COMET assay.
METHODS AND RESULTS:
To explore its potential mechanisms of action, three genotoxic agents, H2O2 which induces DNA damage by the generation of reactive oxygen species, streptozotocin (STZ) by RNS and Methyl methanesulfonate (MMS) by DNA alkylation was used. We found that STZ and H2O2- induced genotoxicity was dose dependently reduced by Morin as assessed by DNA tail length, tail moment, DNA content and olive moment. Since the protective property was found to be specific against oxidative DNA damage, we explored the molecular mechanism underlying Morin-induced Nuclear factor erythroid 2-related factor 2 (Nrf2) activation in pancreatic β-cells as assessed by ARE-driven downstream target genes with Luciferase reporter assay. In addition, Morin inhibited intracellular free radical generation as assessed by using DCFDA and increased the intra cellular antioxidants viz, superoxide dismutase and catalase in INS-1E cells. In addition, Morin attenuated glucose-stimulated insulin secretion following exposure to oxidative stress by STZ (P<0.05).
CONCLUSIONS:
Collectively, our data provide evidence that Morin protects pancreatic β-cells against oxidative stress-induced DNA damage by activating the Nrf2 signaling pathway.

Morin Inhibits Proliferation, Migration, and Invasion of Bladder Cancer EJ Cells via Modulation of Signaling Pathways, Cell Cycle Regulators, and Transcription Factor-Mediated MMP-9 Expression.[Pubmed: 28176369]

Drug Dev Res. 2017 Mar;78(2):81-90.

Preclinical Research Previous studies have shown that Morin exerts diverse pharmacological activities. In this study, we investigated the inhibitory activity of Morin on bladder cancer EJ cells.
METHODS AND RESULTS:
Morin significantly inhibited EJ cell proliferation, which was related to the G1-phase cell cycle arrest together with the reduced expression of cyclin D1, cyclin E, CDK2, and CDK4 via increased expression of p21WAF1. Morin also increased ERK1/2 phosphorylation and decreased JNK and AKT phosphorylation without altering the p38MAPK phosphorylation levels. Morin treatment suppressed the migration and invasion of EJ cells in wound-healing and transwell cell invasion assays. Zymographic and electrophoretic mobility shift assays showed that Morin suppressed the expression of matrix metalloproteinase-9 (MMP-9) via repression of the binding activity of AP-1, Sp-1, and NF-κB.
CONCLUSIONS:
Collectively, these results demonstrate that Morin reduced cyclin D1, cyclin E, CDK2 and CDK4 expression via the induction of p21WAF1 expression, increased ERK1/2 phosphorylation and decreased JNK, and AKT phosphorylation, and prevented MMP-9 expression via the inhibition of transcription factors AP-1, Sp-1, and NF-κB, thereby resulting in the inhibition of growth, migration, and invasion of bladder cancer EJ cells. These results provide a novel insight into the use of Morin in the prevention of bladder cancer.

In vivo

Protective effects of morin on lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting TLR4/NF-κB and activating Nrf2/HO-1 signaling pathways.[Pubmed: 28213269 ]

Int Immunopharmacol. 2017 Apr;45:148-155.

Morin, a bioactive flavonoid extracted from the bark of Moraceae plants and many medicinal herbs, has anti-inflammatory and antioxidative effects. In this research, we explored the protective effects of Morin against lipopolysaccharide (LPS) and d-galactosamine (D-GalN) induced acute liver injury in mice.
METHODS AND RESULTS:
Mice were given an intraperitoneal injection of Morin before LPS and D-GalN treatment and the HepG2 cells were only given Morin to investigate its effects. The results showed that Morin markedly inhibited the production of serum alanine transaminase (ALT), aspartate aminotransferase (AST), interleukin-6 (IL-6), tumor necrosis factor (TNF-α) and hepatic TNF-α, IL-6, and myeloperoxidase (MPO) induced by LPS/D-GalN. In order to evaluate Morin effect in the future, we investigated the expression of nuclear factor E2 related factor 2 (Nrf2), nuclear factor-kappaB (NF-κB), toll like receptor 4 (TLR4) on liver injury.
CONCLUSIONS:
Taken together, these results suggested that Morin could exert the anti-inflammatory and anti-oxidative effects against LPS/D-GalN-induced acute liver injury by activating Nrf2 signal pathways and inhibiting NF-κB activation.

Protocol of Morin

Cell Research

Morin exerts cytoprotective effects against oxidative stress in C2C12 myoblasts via the upregulation of Nrf2-dependent HO-1 expression and the activation of the ERK pathway.[Pubmed: 28035409 ]

Int J Mol Med. 2017 Feb;39(2):399-406.

In the present study, we investigated the cytoprotective efficacy of Morin, a natural flavonoid, against oxidative stress and elucidated the underlying mechanisms in C2C12 myoblasts.
METHODS AND RESULTS:
Our results indicated that Morin treatment prior to hydrogen peroxide (H2O2) exposure significantly increased cell viability and prevented the generation of reactive oxygen species. H2O2-induced comet-like DNA formation and γH2AX phosphorylation were also markedly suppressed by Morin with a parallel inhibition of apoptosis in C2C12 myoblasts, suggesting that Morin prevented H2O2-induced cellular DNA damage. Furthermore, Morin markedly enhanced the expression of heme oxygenase-1 (HO-1) associated with the induction and phosphorylation of nuclear factor-erythroid 2-related factor 2 (Nrf2) and the inhibition of Kelch-like ECH-associated protein 1 (Keap1) expression. Notably, these events were eliminated by transient transfection with Nrf2‑specific small interfering RNA. Additional experiments demonstrated that the activation of the Nrf2/HO-1 pathway by Morin was mediated by the extracellular signal‑regulated kinase (ERK) signaling cascade. This phenomenon was confirmed with suppressed Nrf2 phosphorylation and consequently diminished HO-1 expression in cells treated with a pharmacological inhibitor of ERK.
CONCLUSIONS:
Collectively, these results demonstrated that Morin augments the cellular antioxidant defense capacity through the activation of Nrf2/HO‑1 signaling, which involves the activation of the ERK pathway, thereby protecting C2C12 myoblasts from H2O2-induced oxidative cytotoxicity.

Structure Identification
Food Funct. 2016 Sep 14;7(9):3953-63.

Inhibitory mechanism of morin on α-glucosidase and its anti-glycation properties.[Pubmed: 27549567]

It is important to investigate the inhibition of α-glucosidase due to its correlation with type 2 diabetes.
METHODS AND RESULTS:
Morin was found to exert significant inhibition activity on α-glucosidase in a reversible mixed-type manner with an IC50 value of (4.48 ± 0.04) μM. Analyses of fluorescence and circular dichroism spectra indicated that the formation of the Morin-α-glucosidase complex was driven mainly by hydrophobic forces and hydrogen bonding, and caused the conformational changes of α-glucosidase. The phase diagrams of fluorescence showed that the conformational change process was monophasic without intermediates.
CONCLUSIONS:
Molecular docking indicated that Morin mainly interacted with amino acid residues located close to the active site of α-glucosidase, which may move to cover the active pocket to reduce the binding of the substrate and then inhibit the catalytic activity. Morin was also found to exhibit inhibition in the generation of advanced glycation end products which was related to the long term complications of diabetes.

Morin Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

Morin Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of Morin

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 3.3086 mL 16.5431 mL 33.0863 mL 66.1726 mL 82.7157 mL
5 mM 0.6617 mL 3.3086 mL 6.6173 mL 13.2345 mL 16.5431 mL
10 mM 0.3309 mL 1.6543 mL 3.3086 mL 6.6173 mL 8.2716 mL
50 mM 0.0662 mL 0.3309 mL 0.6617 mL 1.3235 mL 1.6543 mL
100 mM 0.0331 mL 0.1654 mL 0.3309 mL 0.6617 mL 0.8272 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University
Featured Products
New Products
  • Taxifolin

    Catalog No.:BCN5550
    CAS No.:480-18-2
  • Isorhamnetin

    Catalog No.:BCN5551
    CAS No.:480-19-3
  • Aromadendrin

    Catalog No.:BCN5552
    CAS No.:480-20-6
  • Orobol

    Catalog No.:BCN5553
    CAS No.:480-23-9
  • Mellein

    Catalog No.:BCN4785
    CAS No.:480-33-1
  • Eugenin

    Catalog No.:BCN2921
    CAS No.:480-34-2
  • Linarin

    Catalog No.:BCN5554
    CAS No.:480-36-4
  • Pinostrobin

    Catalog No.:BCN5555
    CAS No.:480-37-5
  • Pinocembrin

    Catalog No.:BCN5556
    CAS No.:480-39-7
  • Chrysin

    Catalog No.:BCN5557
    CAS No.:480-40-0
  • Naringenin

    Catalog No.:BCN5558
    CAS No.:480-41-1
  • Isosakuranetin

    Catalog No.:BCN5559
    CAS No.:480-43-3
 

References on Morin

Morin exerts cytoprotective effects against oxidative stress in C2C12 myoblasts via the upregulation of Nrf2-dependent HO-1 expression and the activation of the ERK pathway.[Pubmed:28035409]

Int J Mol Med. 2017 Feb;39(2):399-406.

In the present study, we investigated the cytoprotective efficacy of Morin, a natural flavonoid, against oxidative stress and elucidated the underlying mechanisms in C2C12 myoblasts. Our results indicated that Morin treatment prior to hydrogen peroxide (H2O2) exposure significantly increased cell viability and prevented the generation of reactive oxygen species. H2O2-induced comet-like DNA formation and gammaH2AX phosphorylation were also markedly suppressed by Morin with a parallel inhibition of apoptosis in C2C12 myoblasts, suggesting that Morin prevented H2O2-induced cellular DNA damage. Furthermore, Morin markedly enhanced the expression of heme oxygenase-1 (HO-1) associated with the induction and phosphorylation of nuclear factor-erythroid 2-related factor 2 (Nrf2) and the inhibition of Kelch-like ECH-associated protein 1 (Keap1) expression. Notably, these events were eliminated by transient transfection with Nrf2specific small interfering RNA. Additional experiments demonstrated that the activation of the Nrf2/HO-1 pathway by Morin was mediated by the extracellular signalregulated kinase (ERK) signaling cascade. This phenomenon was confirmed with suppressed Nrf2 phosphorylation and consequently diminished HO-1 expression in cells treated with a pharmacological inhibitor of ERK. Collectively, these results demonstrated that Morin augments the cellular antioxidant defense capacity through the activation of Nrf2/HO1 signaling, which involves the activation of the ERK pathway, thereby protecting C2C12 myoblasts from H2O2-induced oxidative cytotoxicity.

Protective effects of morin on lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting TLR4/NF-kappaB and activating Nrf2/HO-1 signaling pathways.[Pubmed:28213269]

Int Immunopharmacol. 2017 Apr;45:148-155.

Morin, a bioactive flavonoid extracted from the bark of Moraceae plants and many medicinal herbs, has anti-inflammatory and antioxidative effects. In this research, we explored the protective effects of Morin against lipopolysaccharide (LPS) and d-galactosamine (D-GalN) induced acute liver injury in mice. Mice were given an intraperitoneal injection of Morin before LPS and D-GalN treatment and the HepG2 cells were only given Morin to investigate its effects. The results showed that Morin markedly inhibited the production of serum alanine transaminase (ALT), aspartate aminotransferase (AST), interleukin-6 (IL-6), tumor necrosis factor (TNF-alpha) and hepatic TNF-alpha, IL-6, and myeloperoxidase (MPO) induced by LPS/D-GalN. In order to evaluate Morin effect in the future, we investigated the expression of nuclear factor E2 related factor 2 (Nrf2), nuclear factor-kappaB (NF-kappaB), toll like receptor 4 (TLR4) on liver injury. Taken together, these results suggested that Morin could exert the anti-inflammatory and anti-oxidative effects against LPS/D-GalN-induced acute liver injury by activating Nrf2 signal pathways and inhibiting NF-kappaB activation.

Inhibitory mechanism of morin on alpha-glucosidase and its anti-glycation properties.[Pubmed:27549567]

Food Funct. 2016 Sep 14;7(9):3953-63.

It is important to investigate the inhibition of alpha-glucosidase due to its correlation with type 2 diabetes. Morin was found to exert significant inhibition activity on alpha-glucosidase in a reversible mixed-type manner with an IC50 value of (4.48 +/- 0.04) muM. Analyses of fluorescence and circular dichroism spectra indicated that the formation of the Morin-alpha-glucosidase complex was driven mainly by hydrophobic forces and hydrogen bonding, and caused the conformational changes of alpha-glucosidase. The phase diagrams of fluorescence showed that the conformational change process was monophasic without intermediates. Molecular docking indicated that Morin mainly interacted with amino acid residues located close to the active site of alpha-glucosidase, which may move to cover the active pocket to reduce the binding of the substrate and then inhibit the catalytic activity. Morin was also found to exhibit inhibition in the generation of advanced glycation end products which was related to the long term complications of diabetes.

Morin activates the Nrf2-ARE pathway and reduces oxidative stress-induced DNA damage in pancreatic beta cells.[Pubmed:28216051]

Eur J Pharmacol. 2017 Apr 15;801:9-18.

Oxidative stress is an important factor contributing to the pathogenesis of diabetes and its complications. In our earlier study, we demonstrated the antidiabetic efficacy of Morin by regulating key enzymes of carbohydrate metabolism in diabetic rats. The present study was designed to assess the antigenotoxic potential of Morin in pancreatic beta-cells, using the COMET assay. To explore its potential mechanisms of action, three genotoxic agents, H2O2 which induces DNA damage by the generation of reactive oxygen species, streptozotocin (STZ) by RNS and Methyl methanesulfonate (MMS) by DNA alkylation was used. We found that STZ and H2O2- induced genotoxicity was dose dependently reduced by Morin as assessed by DNA tail length, tail moment, DNA content and olive moment. Since the protective property was found to be specific against oxidative DNA damage, we explored the molecular mechanism underlying Morin-induced Nuclear factor erythroid 2-related factor 2 (Nrf2) activation in pancreatic beta-cells as assessed by ARE-driven downstream target genes with Luciferase reporter assay. In addition, Morin inhibited intracellular free radical generation as assessed by using DCFDA and increased the intra cellular antioxidants viz, superoxide dismutase and catalase in INS-1E cells. In addition, Morin attenuated glucose-stimulated insulin secretion following exposure to oxidative stress by STZ (P<0.05). Collectively, our data provide evidence that Morin protects pancreatic beta-cells against oxidative stress-induced DNA damage by activating the Nrf2 signaling pathway.

Morin Inhibits Proliferation, Migration, and Invasion of Bladder Cancer EJ Cells via Modulation of Signaling Pathways, Cell Cycle Regulators, and Transcription Factor-Mediated MMP-9 Expression.[Pubmed:28176369]

Drug Dev Res. 2017 Mar;78(2):81-90.

Preclinical Research Previous studies have shown that Morin exerts diverse pharmacological activities. In this study, we investigated the inhibitory activity of Morin on bladder cancer EJ cells. Morin significantly inhibited EJ cell proliferation, which was related to the G1-phase cell cycle arrest together with the reduced expression of cyclin D1, cyclin E, CDK2, and CDK4 via increased expression of p21WAF1. Morin also increased ERK1/2 phosphorylation and decreased JNK and AKT phosphorylation without altering the p38MAPK phosphorylation levels. Morin treatment suppressed the migration and invasion of EJ cells in wound-healing and transwell cell invasion assays. Zymographic and electrophoretic mobility shift assays showed that Morin suppressed the expression of matrix metalloproteinase-9 (MMP-9) via repression of the binding activity of AP-1, Sp-1, and NF-kappaB. Collectively, these results demonstrate that Morin reduced cyclin D1, cyclin E, CDK2 and CDK4 expression via the induction of p21WAF1 expression, increased ERK1/2 phosphorylation and decreased JNK, and AKT phosphorylation, and prevented MMP-9 expression via the inhibition of transcription factors AP-1, Sp-1, and NF-kappaB, thereby resulting in the inhibition of growth, migration, and invasion of bladder cancer EJ cells. These results provide a novel insight into the use of Morin in the prevention of bladder cancer. Drug Dev Res 78 : 81-90, 2017. (c) 2017 Wiley Periodicals, Inc.

Description

Morin, a plant-derived flavonoid, possesses low antioxidant activity. Morin is a fluorescing chelating agent used in aluminum speciation.

Keywords:

Morin,480-16-0,2'-Hydroxypelargidenolon 1522; 2',3,4',5,7-Pentahydroxyflavone; 2',4',5,7-Tetrahydroxyflavonol,Natural Products, buy Morin , Morin supplier , purchase Morin , Morin cost , Morin manufacturer , order Morin , high purity Morin

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: